Infusion device data set analyzer

• US 20060259327A1
• Filed: 05/11/2006
• Published: 11/16/2006
• Est. Priority Date: 05/11/2005
• Status: Active Grant

• Current Assignee: Carefusion 303 Incorporated (Becton Dickinson & Co)
• Original Assignee: Carefusion 303 Incorporated (Becton Dickinson & Co)
• Inventors: Hoag, Robert E.
• Granted Patent: US 8,798,979 B2
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/00 Administration; Management
• CPC Class Codes: G16H 15/00 ICT specially adapted for medical reports, e.g. generation or transmission thereof
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

A system and method for evaluating drug data sets is provided. The system and method includes identifying when entries in a current data set differ from a data set comprising an aggregate of entries for a plurality of institutions, and prompting a user to determine if a change in the current data set should be changed. The system and method also identifies cases where different dose units are used for the same drug. A report is generated noting exceptions.

Claims

1. A system for analyzing a drug data set for clinical appropriateness, comprising:

an input device for inputting a first drug data set to be analyzed, the first drug data set having a plurality of drugs and associated with each drug, a plurality of data elements comprising data relevant to administration of the drug to patients, the data elements including dosing information;

a memory having an established drug data set, the established drug data set having a plurality of drugs and associated with each drug, a plurality of data elements comprising data relevant to administration of the drug to patients, the data elements including dosing information;

a processor connected with the memory to receive the established drug data set and connected to the input device to receive the first drug data set, the processor programmed to compare the first drug data set against the established drug data set, the comparison including identifying matches between the drugs of the first drug data set with the drugs of the established drug data set and comparing the dosing information of any identified matches; and

a reporting device connected with the processor to report the results of the comparison.

2. The system of claim 1 wherein:

the processor is also programmed to identify a drug contained in the first drug data set that is not contained in the established drug data set; and

the reporting device also reports such unmatched drug as an exception.

3. The system of claim 1 wherein:

the processor is also programmed to identify differing dosing units used for the drugs contained in the first drug data set that are not used for the same drugs in the established drug data set; and

the reporting device also reports such dosing unit'"'"'s difference.

4. The system of claim 1 wherein the system prompts a user to change the dosing units of a drug contained in the first drug data set upon report of differing dosing units used for the same drug contained in the established drug data set.

5. The system of claim 3 wherein the processor is also programmed to automatically convert the dosing units of a drug in the first drug data set to the dosing units of the same drug in the established drug data set prior to the comparison by the processor.

6. The system of claim 1 wherein:

the processor is also programmed to identify differing dosing limits used for each of the drugs contained in the first drug data set that are not used for same drugs in the established drug data set; and

the reporting device also reports such dosing limits difference.

7. The system of claim 1 wherein the system prompts a user to change the dosing limits of a drug contained in the first drug data set upon report of differing dosing limits used for the same drug contained in the established drug data set.

8. The system of claim 1 wherein:

the processor is also programmed to automatically convert the dosing limits of a drug in the first drug data set to the dosing limits of the-same drug in the established drug data set prior to comparison by the processor.

9. The system of claim 1 wherein:

the memory has a plurality of established drug data sets;

the processor is connected to the memory to receive the plurality of established drug data sets; and

the processor is programmed to compare the first drug data set against the plurality of established drug data sets.

10. The system of claim 9 wherein:

the processor is also programmed to identify differing dosing units for a drug contained in the first drug data set if less than two established drug data sets utilize the same dosing units for the same drug; and

the reporting device also reports such dosing unit'"'"'s difference as an “

exception.”

11. The system of claim 9 wherein:

the processor is also programmed to identify the number of differing dosing limits used for each of the drugs contained in the first drug data set that are not used for each of the same drugs in the plurality of established drug data sets; and

the reporting device also reports such number.

12. The system of claim 9 wherein the processor is programmed to determine an acceptable variance range of minimum and maximum dosing limits for any drug found among the plurality of established drug data sets.

13. The system of claim 12 wherein:

the processor is programmed to identify a minimum dosing limit of a drug contained in the first drug data set falling outside the acceptable variance range; and

the reporting device also reports such identification.

14. The system of claim 12 wherein:

the processor is programmed to identify a maximum dosing limit of a drug contained in the first drug data set falling outside the acceptable variance range; and

the reporting device also reports such identification.

15. The system of claim 1 wherein the established drug data set represents a data set generated by a medical care facility.

16. The system of claim 9 wherein each of the plurality of established drug data sets represents a data set generated by different medical care facilities.

17. The system of claim 1 wherein the system is part of an editor program used to create a drug data set.

18. The system of claim 1 wherein the system is housed on a portable computing device.

19. The system of claim 1 wherein the first drug data set is housed on a first device and the established drug data set and the processor is housed on a second device.

20. A computerized method for analyzing a drug data set for clinical appropriateness, comprising:

receiving a first drug data set to be analyzed, the first drug data set having a plurality of drugs and associated with each drug, a plurality of data elements comprising data relevant to administration of the drug to patients by an infusion pump, the data elements including infusion dosing information;

maintaining a reference data base having an established drug data set, the established drug data set having a plurality of drugs and associated with each drug, a plurality of data elements relevant to administration of the drug to patients by an infusion pump, the data elements including infusion dosing information;

comparing the first drug data set against the established drug data set, the comparing including identifying matches between the drugs of the first drug data set with the drugs of the established drug data set and comparing the infusion dosing information of any identified matches; and

reporting the results of the comparison.

21. The method of claim 20 wherein the step of maintaining a reference data base comprises maintaining a reference data base having a plurality of established drug data sets.